William Ganley, PhD, is Head of Computational Pharmaceutics at Nanopharm, an Aptar Pharma company, where he is responsible for developing in silico methodologies and data analytics services to support OINDP companies through clinical development to regulatory approval. Holding an MChem from the University of Southampton and a PhD from the University of Bristol, Dr Ganley has presented work on physical chemistry and pharmaceutics at multiple international conferences and published several peer-reviewed articles. He was awarded the Faculty of Science Prize for Physical Sciences and the Best Doctoral Research Thesis Prize by the Faculty of Science for his PhD.